Product Information
AVALIDE 150-12.5 MG TABLET is a brand product labeled by Sanofi-Aventis U.S. LLC, priced at $8.9109 per EA under NDC 00024585530. Its NADAC has been published 270 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the irbesartan and hydrochlorothiazide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
12.5; 150 mg/1; mg/1
Manufacturer
Sanofi-Aventis U.S. LLCNDC
00024585530
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
10/22/2025
Active Ingredients
HYDROCHLOROTHIAZIDE; IRBESARTANApproval Type
New Drug (NDA)
FDA Application
NDA020758On Market Since
1/1/2013
Pharmacological Classes
Price Statistics
The NADAC for AVALIDE 150-12.5 MG TABLET has been published 270 times since Nov 28, 2013, and over the history we have for it it has risen 134.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.9109 per EA |
|---|---|
| All-time high | $8.9109 (Jun 24, 2026) |
| All-time low | $3.7990 (Nov 28, 2013) |
| 52-week high | $8.9109 |
| 52-week low | $8.9109 |
| Median price | $6.6100 |
| Average price | $6.2988 |
| Largest weekly change | +26.8% (Sep 17, 2025) |
| Weeks tracked | 270 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the irbesartan and hydrochlorothiazide market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of AVALIDE 150-12.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for AVALIDE 150-12.5 MG TABLET, manufactured by Sanofi-Aventis U.S. LLC, is $8.9109 per EA (NDC 00024585530), effective Jun 24, 2026.
How has the price of AVALIDE 150-12.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for AVALIDE 150-12.5 MG TABLET has risen 134.6%. It has been tracked across 270 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for AVALIDE 150-12.5 MG TABLET?
Since Nov 28, 2013, the NADAC for AVALIDE 150-12.5 MG TABLET has ranged from a low of $3.7990 (Nov 28, 2013) to a high of $8.9109 (Jun 24, 2026), with a median of $6.6100 per EA.
Are there cheaper alternatives to AVALIDE 150-12.5 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of AVALIDE 150-12.5 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures AVALIDE 150-12.5 MG TABLET?
AVALIDE 150-12.5 MG TABLET (NDC 00024585530) is labeled by Sanofi-Aventis U.S. LLC, and CMS classifies it as a brand product.
Related Drugs
Same classification